34 results
8-K
EX-99.1
LGVN
Longeveron Inc - Ordinary Shares
10 May 24
Longeveron Announces Board of Directors Planned Transitions
4:30pm
for their leadership, service and countless contributions,” said Joshua Hare, M.D., Co-founder, Chief Science Officer and Chairman of the Board … leadership of biopharmaceutical licensing transactions will bring tremendous value to Longeveron as we continue to advance Lomecel-BTM, our
8-K
LGVN
Longeveron Inc - Ordinary Shares
20 Jul 23
Longeveron Appoints Lisa Locklear as Chief Financial Officer
8:30am
” or the “Company”) announced the appointment of Lisa Locklear to the Longeveron executive leadership team in the role of Executive Vice President and Chief
8-K
EX-99.1
9n6 9pnfv73c
20 Jul 23
Longeveron Appoints Lisa Locklear as Chief Financial Officer
8:30am
8-K
4gvoj 6pp7j4fkph6g25
5 Jul 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
lnx7e6kf yi3vdj5
23 Jun 23
Regulation FD Disclosure
8:00am
DEF 14A
yk9ouvosw2c0ppo
13 May 22
Definitive proxy
4:10pm
8-K
EX-99.1
7fap302 aizn0
9 May 22
Longeveron Announces CEO Transition
4:26pm
8-K
bb0w36dfc3pbavtdw
5 Apr 22
Longeveron Expands Executive Leadership Team; Appoints
4:01pm
8-K
EX-99.1
bt0qrralqmpn
5 Apr 22
Longeveron Expands Executive Leadership Team; Appoints
4:01pm
8-K
EX-99.1
g9ci8 9j8
17 Feb 22
Longeveron Adds Seasoned Biotech Executive Todd Girolamo to Its Board of Directors
4:02pm
8-K
EX-99.1
wkxiw eyp
10 Jan 22
Regulation FD Disclosure
10:38am
424B3
yetr j4vthn1kv714q5j
22 Dec 21
Prospectus supplement
5:07pm
8-K
EX-99.1
btko2fu2q
1 Oct 21
Regulation FD Disclosure
4:02pm